StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Friday morning. The firm issued a sell rating on the biopharmaceutical ...
Anamorelin hydrochloride is under clinical development by Helsinn Healthcare and currently in Phase II for Obesity.
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report ...
Weight loss drugs Bariatric surgery (weight loss surgery) Why is it so hard to lose weight and keep it off? Obesity is a ...
The expansive roles of gut peptides suggest they may be leveraged in a variety of applied research domains. Their modular structure, receptor-specificity, and potential bioactivity make them ...
H2 receptor blockers are drugs that are used to treat gastroesophageal reflux disease (GERD) and peptic ulcers. This drug is effective, cheap, and safe for relieving heartburn. It is available by ...
The discovery of leptin and gut hormones as major neuroendocrine regulators of bodyweight is leading the way to the development of attractive therapeutic approaches to the long-term manipulation ...
Ghrelin stimulates appetite ... Emerging evidence suggests that GLP-1 receptor-expressing neurons in the DVC play pivotal roles in energy homeostasis, especially appetite suppression and weight ...
The scientists achieved this result again by removing the receptors for the hunger hormone ghrelin from these neurons. Prior studies have shown that the hippocampus of animals, including non-human ...